RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients

Stock Information for Redhill Biopharma Ltd.

Loading

Please wait while we load your information from QuoteMedia.